Literature DB >> 23237960

An Usher syndrome type 1 patient diagnosed before the appearance of visual symptoms by MYO7A mutation analysis.

Hidekane Yoshimura1, Satoshi Iwasaki, Yukihiko Kanda, Hiroshi Nakanishi, Toshinori Murata, Yoh-ichiro Iwasa, Shin-ya Nishio, Yutaka Takumi, Shin-ichi Usami.   

Abstract

Usher syndrome type 1 (USH1) appears to have only profound non-syndromic hearing loss in childhood and retinitis pigmentosa develops in later years. This study examined the frequency of USH1 before the appearance of visual symptoms in Japanese deaf children by MYO7A mutation analysis. We report the case of 6-year-old male with profound hearing loss, who did not have visual symptoms. The frequency of MYO7A mutations in profound hearing loss children is also discussed. We sequenced all exons of the MYO7A gene in 80 Japanese children with severe to profound non-syndromic HL not due to mutations of the GJB2 gene (ages 0-14 years). A total of nine DNA variants were found and six of them were presumed to be non-pathogenic variants. In addition, three variants of them were found in two patients (2.5%) with deafness and were classified as possible pathogenic variants. Among them, at least one nonsense mutation and one missense mutation from the patient were confirmed to be responsible for deafness. After MYO7A mutation analysis, the patient was diagnosed with RP, and therefore, also diagnosed with USH1. This is the first case report to show the advantage of MYO7A mutation analysis to diagnose USH1 before the appearance of visual symptoms. We believed that MYO7A mutation analysis is valid for the early diagnosis of USH1.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237960     DOI: 10.1016/j.ijporl.2012.11.007

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  USH2 caused by GPR98 mutation diagnosed by massively parallel sequencing in advance of the occurrence of visual symptoms.

Authors:  Hideaki Moteki; Hidekane Yoshimura; Hela Azaiez; Kevin T Booth; A Eliot Shearer; Christina M Sloan; Diana L Kolbe; Toshinori Murata; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-05       Impact factor: 1.547

2.  Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome.

Authors:  Christine Neuhaus; Tobias Eisenberger; Christian Decker; Sandra Nagl; Cornelia Blank; Markus Pfister; Ingo Kennerknecht; Cornelie Müller-Hofstede; Peter Charbel Issa; Raoul Heller; Bodo Beck; Klaus Rüther; Diana Mitter; Klaus Rohrschneider; Ute Steinhauer; Heike M Korbmacher; Dagmar Huhle; Solaf M Elsayed; Hesham M Taha; Shahid M Baig; Heidi Stöhr; Markus Preising; Susanne Markus; Fabian Moeller; Birgit Lorenz; Kerstin Nagel-Wolfrum; Arif O Khan; Hanno J Bolz
Journal:  Mol Genet Genomic Med       Date:  2017-07-06       Impact factor: 2.183

3.  Cochlear Implantation From the Perspective of Genetic Background.

Authors:  Shin-Ichi Usami; Shin-Ya Nishio; Hideaki Moteki; Maiko Miyagawa; Hidekane Yoshimura
Journal:  Anat Rec (Hoboken)       Date:  2020-02-06       Impact factor: 2.064

4.  Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing.

Authors:  Hidekane Yoshimura; Maiko Miyagawa; Kozo Kumakawa; Shin-Ya Nishio; Shin-Ichi Usami
Journal:  J Hum Genet       Date:  2016-01-21       Impact factor: 3.172

5.  An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients.

Authors:  Crystel Bonnet; Zied Riahi; Sandra Chantot-Bastaraud; Luce Smagghe; Mélanie Letexier; Charles Marcaillou; Gaëlle M Lefèvre; Jean-Pierre Hardelin; Aziz El-Amraoui; Amrit Singh-Estivalet; Saddek Mohand-Saïd; Susanne Kohl; Anne Kurtenbach; Ieva Sliesoraityte; Ditta Zobor; Souad Gherbi; Francesco Testa; Francesca Simonelli; Sandro Banfi; Ana Fakin; Damjan Glavač; Martina Jarc-Vidmar; Andrej Zupan; Saba Battelino; Loreto Martorell Sampol; Maria Antonia Claveria; Jaume Catala Mora; Shzeena Dad; Lisbeth B Møller; Jesus Rodriguez Jorge; Marko Hawlina; Alberto Auricchio; José-Alain Sahel; Sandrine Marlin; Eberhart Zrenner; Isabelle Audo; Christine Petit
Journal:  Eur J Hum Genet       Date:  2016-07-27       Impact factor: 4.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.